ArticleBreast cancer research and treatment2025

Changes in HER2low and HER2-ultralow status in 47 advanced breast carcinoma core biopsies, matching surgical specimens, and their distant metastases assessed by conventional light microscopy, digital pathology, and artificial intelligence.

Anikó Kovács et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.